Anti-vascular Endothelial Growth Factor Outpatient Treatment Patterns in Patients with Exudative Age-related Macular Degeneration from a Japanese Hospital Claims Database
**Purpose:** To identify outpatient treatment patterns of patients with exudative age-related macular degeneration (AMD) who received approved anti–vascular endothelial growth factor (VEGF) therapy, using real-world data from hospitals in Japan. **Methods:** A hospital claims database was retrospec...
Main Authors: | Tomohiro Iida, Aya Narimatsu, Kenji Adachi, Edward CY Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | http://jheor.scholasticahq.com/article/9887-anti-vascular-endothelial-growth-factor-outpatient-treatment-patterns-in-patients-with-exudative-age-related-macular-degeneration-from-a-japanese-hospital-claims-database.pdf |
Similar Items
-
Vitreomacular traction affects anti-vascular endothelial growth factor treatment outcomes for exudative age-related macular degeneration
by: Krishnan, Radhika, et al.
Published: (2015) -
Change of retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in exudative age-related macular degeneration
by: Moosang Kim, et al.
Published: (2016-01-01) -
Analysis on Conbercept for exudative age-related macular degeneration
by: Kun Li, et al.
Published: (2017-12-01) -
No association between complement factor H gene polymorphism and exudative age-related macular degeneration in Japanese.
by: Goto, Norimoto
Published: (2011) -
Effect of ranibizumab on serous and vascular pigment epithelial detachments associated with exudative age-related macular degeneration
by: Panos GD, et al.
Published: (2013-07-01)